![Kristine Ball](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristine Ball
Amministratore Delegato presso
Antiva Biosciences, Inc.
Patrimonio netto: - $ in data 31/08/2026
Profilo
Kristine McClintock Ball is currently President & Chief Executive Officer at Antiva Biosciences, Inc. since 2023.
Also holds positions as Director at the National Kidney Foundation of Northern California and Independent Director at Oruka Therapeutics, Inc. starting in 2024.
Former roles include Chief Executive Officer & Director at Soteria Biotherapeutics, Inc. from 2020 to 2022; Independent Director at Forty Seven LLC from 2018 to 2020; Independent Director at Atreca, Inc. from 2020 to 2024; Chief Financial Officer & SVP-Corporate Strategy at Menlo Therapeutics, Inc. from 2017 to 2020; Chief Financial Officer & Senior Vice President at Relypsa, Inc. from 2012 to 2016; CFO, Senior VP-Administration & Finance at KAI Pharmaceuticals, Inc. from 2005 to 2012; Vice President-Finance at Exelixis, Inc. from 2000 to 2005; and Senior Manager at Ernst & Young LLP from 1998 to 2000.
Education includes undergraduate studies at Babson College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
-.--% | 02/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Posizioni attive di Kristine Ball
| Società | Posizione | Inizio |
|---|---|---|
National Kidney Foundation of Northern California
 National Kidney Foundation of Northern California The National Kidney Foundation of Northern California is a company based in San Francisco, CA. | Direttore/Membro del Consiglio | - |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Amministratore Delegato | 27/04/2023 |
Precedenti posizioni note di Kristine Ball
| Società | Posizione | Fine |
|---|---|---|
| ATRECA, INC. | Direttore/Membro del Consiglio | 01/01/2024 |
Soteria Biotherapeutics, Inc.
 Soteria Biotherapeutics, Inc. BiotechnologyHealth Technology Develops T-cell engagers to treat patients with solid tumor cancers | Amministratore Delegato | 01/08/2022 |
| FORTY SEVEN, INC. | Direttore/Membro del Consiglio | 07/04/2020 |
| YARROW BIOSCIENCE, INC. | Direttore Finanziario/CFO | 01/03/2020 |
| RELYPSA INC | Direttore Finanziario/CFO | 01/10/2016 |
Formazione di Kristine Ball
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
National Kidney Foundation of Northern California
National Kidney Foundation of Northern California The National Kidney Foundation of Northern California is a company based in San Francisco, CA. | |
Soteria Biotherapeutics, Inc.
Soteria Biotherapeutics, Inc. BiotechnologyHealth Technology Develops T-cell engagers to treat patients with solid tumor cancers | Health Technology |
